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Abstract
With the help of a community-based survey, we assess the potential effect of circumcision on the 
HIV epidemic among men who have sex with men (MSM) in San Francisco. Only a small 
minority of MSM would both derive benefit from circumcision (i.e., were uncircumcised, HIV-
negative, predominantly insertive, and reported unprotected insertive anal sex) and be willing to 
participate in circumcision trials (0.7%) or be circumcised if proven effective as a prevention 
strategy (0.9%). Circumcision would have limited public health significance for MSM in San 
Francisco.
Men who have sex with men (MSM) continue to be disproportionately affected by human 
immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) in the 
developed world and are becoming the center of HIV epidemics in some developing 
countries.1 However, evidence-based HIV prevention approaches have not been able to halt 
MSM epidemics, with HIV incidence resurgent in some countries and newly rising in others.
1,2
 A desire to consider adult male circumcision (MC) as a prevention strategy for MSM is 
driven by its demonstrated ability to reduce HIV incidence by as much as 60% in 
randomized controlled trials among hetero-sexual men.3–5
However, the role circumcision might play in preventing HIV acquisition for MSM is more 
uncertain than for heterosexual men. Circumcision would only protect the insertive partner 
during unprotected anal sex, yet many men also engage in receptive anal sex, which confers 
an approximately 4-fold higher per-contact risk of HIV transmission.6 This may out-weigh 
any protective effect circumcision would have for men who assume both sexual roles.7 A 
meta-analysis of observational studies showed that circumcision status was associated with a 
statistically nonsignificant 14% reduction in HIV infection among MSM in the sample 
overall.8 A recent prospective cohort study of Australian gay men found that circumcision 
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was associated with a reduction in HIV incidence in those men who reported a preference 
for the insertive role during anal sex.9 If circumcision were proven to be an effective HIV 
prevention strategy for primarily “insertive” MSM, several variables would influence if and 
how it could reduce new HIV infections at the population level. Factors affecting the 
potential public health impact of a MC campaign within a given population of MSM include 
the protective efficacy, HIV prevalence, current rates of circumcision, insertive and receptive 
role segregation, and the willingness of MSM to be circumcised for this indication. In 
addition, if men are circumcised to reduce HIV infection risk while substantially increasing 
their risk practices (i.e., risk compensation), any protective effect of circumcision could be 
diluted, or possibly overwhelmed.10
In this report, we use data from the 2008 National HIV Behavioral Surveillance (NHBS) 
survey for MSM in San Francisco to predict the potential maximum benefit from a MC 
intervention in this population. NHBS is a Centers for Disease Control and Prevention-
coordinated, multicity survey that makes use of time-location-sampling to recruit 
participants at venues where MSM frequently congregate. Details of the sampling and 
recruitment procedures have been described else- where.11,12 Briefly, data were collected 
from MSM consecutively intercepted at randomly selected venue-day-time periods between 
July 2008 and December 2008 in San Francisco. Interviewer-administered surveys were 
conducted with eligible participants (i.e., randomly intercepted at an MSM venue, male sex 
at birth and currently, age 18 years and older, resident of the Bay Area); data were recorded 
on handheld computers, and blood samples were collected for HIV antibody testing. In 
addition to the standard national core measures of demographic and risk behavior 
information, the local San Francisco questionnaire included questions on the counts of 
episodes of insertive and receptive anal intercourse with each of up to 5 partners in the 
preceding 6 months, self-reported current circumcision status (HIV-negative men only), and 
willingness to be circumcised, if not already. Two 4-point scale (from “Very likely” to “Very 
unlikely”) items assessed participants’ willingness to (1) participate in a circumcision trial; 
and (2) be circumcised in the future if evidence supports the efficacy of circumcision in 
reducing the risk of HIV infection in MSM. To calculate the proportion of men who might 
hypothetically benefit from a MC intervention, we calculated the proportion of men who 
were HIV negative, uncircumcised, engaging in predominantly unprotected insertive anal 
sex, and willing to undergo MC. The study protocol was reviewed and approved by the 
Centers for Disease Control and Prevention Institutional Review Board and the Committee 
for Human Research of the University of California, San Francisco.
During the NHBS survey, study staff enumerated 10,279 men attending 117 randomly 
selected venue-day-time periods and consecutively approached 1520. Of these, 1121 (74%) 
agreed to eligibility screening; 781 (70%) were eligible; 590 (76%) agreed to participate in 
the survey and completed the interview. During the interview, 69 men either identified as 
heterosexual and did not report any male partners in the past 12 months or their electronic 
data were lost, leaving a sample of 521 unique MSM, who were diverse in terms of race/
ethnicity, age, education achievement, and country of birth: 53% were white, 25% Latino, 
7% black, and 7% Asian; ages ranged from 18 to 79 years, with a median of 36 years; most 
men (85%) had some college education or higher.
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As seen in Figure 1, in our sample of 521 men, 115 (22.1%) were HIV-positive. Of the 406 
HIV-negative men, 327 (80.5%) were already circumcised, leaving 79 (19.5%) for whom 
circumcision may have an additional preventive benefit. Of these, 17 (21.5%) said they 
would be willing to participate in circumcision trials for MSM and 22 (27.8%) said they 
would get circumcised if there were evidence of efficacy. However, to explore the likely size 
of the population for whom circumcision would be a relevant intervention, we further 
characterize those reporting unprotected insertive anal intercourse and those willing to be 
circumcised in a trial or if recommended for prevention. Of the 79 men who were HIV-
negative and uncircumcised, 36 (8.9%) reported not using condoms consistently. Notably 
rates of reported unprotected anal intercourse did not differ between circumcised and 
uncircumcised men (P = 0.56). Four levels of reported frequency of insertive anal 
intercourse (IAI) were defined as follows: at least 20% of anal sex acts were IAI (i.e., 80% 
of the time reported some receptive anal intercourse), 40%, 60%; and 80%. Of those HIV-
negative men who predominantly engaged in IAI (i.e., ≥80% IAI, unprotected at least some 
of the time), only 3 (0.7%) were willing to participate in an MSM circumcision trial and 
only 4 (0.9%) were willing to get circumcised if the evidence from clinical studies found it 
was safe and efficacious. These estimates do not vary by level of reported IAI; that is, men 
who engaged in predominantly IAI were as willing to be in a trial or get circumcised as men 
who were predominantly receptive.
Our community survey results suggest that MC would have limited public health 
significance for MSM in San Francisco. High existing rates of MC, coupled with low rates 
of predominant IAI and lack of interest in undergoing the procedure for HIV prevention 
limit the potential impact of this intervention, even if it were found to be efficacious. 
Although our results may have limited generalizability, the parameters that affect the utility 
of circumcision for HIV prevention are not expected to vary greatly among MSM in other 
US cities. Both national samples of US men and MSM have found similarly high rates of 
circumcision.13,14 Moreover, there is little reason to believe that sexual behaviors of MSM in 
other US cities would differ significantly from that of MSM in San Francisco. Therefore, it 
may be likely that MC among MSM would have little effect on HIV transmission throughout 
the United States.
Acknowledgments
Supported by the US Centers for Disease Control and Prevention (U62-PS000961) and National Institutes of 
Allergy and Infectious Diseases MP3 grant (1R01AI083060) (to S.B. and J.F.).
REFERENCES
1. van Griensven F, de Lind van Wijngaarden JW, Baral S, et al. The global epidemic of HIV infection 
among men who have sex with men. Curr Opin HIV AIDS 2009; 4:300–307. [PubMed: 19532068] 
2. Sullivan PS, Hamouda O, Delpech V, et al. Reemergence of the HIV epidemic among men who have 
sex with men in North America, Western Europe, and Australia, 1996–2005. Ann Epidemiol 2009; 
19:423–431.
3. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, 
Uganda: A randomized trial. Lancet 2007; 369:657–666. [PubMed: 17321311] 
4. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in 
Kisumu, Kenya: A randomized controlled trial. Lancet 2007; 369:643–656. [PubMed: 17321310] 
Wei et al. Page 3





















5. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male 
circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Med 2005; 2:e298. 
[PubMed: 16231970] 
6. Vittinghoff E, Douglas J, Judson F, et al. Per-contact risk of human immunodeficiency virus 
transmission between male sexual partners. Am J Epidemiol 1999; 150:306–311. [PubMed: 
10430236] 
7. Gust DA, Wiegand RE, Kretsinger K, et al. Circumcision status and HIV infection among MSM: 
Reanalysis of a phase III HIV vaccine clinical trial. AIDS 2010; 24:1135–1143. [PubMed: 
20168206] 
8. Millett GA, Flores SA, Marks G, et al. Circumcision stats and risk of HIV and sexually transmitted 
infections among men who have sex with men: A meta-analysis. JAMA 2008; 300:1674–1684. 
[PubMed: 18840841] 
9. Templeton DJ, Jin F, Prestage GP, et al. Circumcision and risk of sexually transmissible infections in 
a community-based cohort of HIV-negative homosexual men in Sydney, Australia. J Infect Dis 
2009; 200:1813–1819. [PubMed: 19911990] 
10. Templeton DJ, Millet GA, Grulich AE. Male circumcision to reduce the risk of HIV and sexually 
transmitted infections among men who have sex with men. Curr Opin Infect Dis 2010; 23:45–52. 
[PubMed: 19935420] 
11. MacKellar D, Gallagher KM, Finlayson T, et al. Surveillance of HIV risk and prevention behaviors 
of men who have sex with men—a national application of venue based, time-space sampling. 
Public Health Rep 2007; 122:39–47. [PubMed: 17354526] 
12. Raymond HF, Chen YH, Stall RD, et al. Adolescent experiences of discrimination, harassment, 
connectedness to community and comfort with sexual orientation reported by adult men who have 
sex with men as a predictor of adult HIV status. AIDS Behav In press.
13. Xu F, Markowitz LE, Sternberg MR, et al. Prevalence of circumcision and herpes simplex virus 
type 2 infection in men in the United States: The National Health and Nutrition Examination 
Survey (NHANES), 1999–2004. Sex Transm Dis 2007; 34:479–484.
14. Jozkowski K, Rosenberger JG, Schick V, et al. Relations between circumcision status, sexually 
transmitted infection history, and HIV serostatus among a national sample of men who have sex 
with men in the United States. AIDS Patient Care STDS 2010; 24:1–6. [PubMed: 20095911] 
Wei et al. Page 4






















Circumcision status and willingness to participate in circumcision trials and be circumcised 
if proven efficacious among MSM in San Francisco. Trial willing indicates willing to 
participate in a circumcision trial; Evidence willing, willing to be circumcised if scientific 
evidence supports efficacy of circumcision in preventing HIV; UIAI, unprotected insertive 
anal intercourse.
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